Browse the evidence

Ceramide accumulation in specific tissues (adipose, liver, muscle) during aging and high-fat diet consumption drives insulin resistance and inflammation, linking sphingolipid metabolism to type 2 diabetes.

High levels of specific lipids called ceramides, particularly C16-ceramide, are linked to insulin resistance and type 2 diabetes. This suggests that managing lipid metabolism and reducing the production of these specific lipids (potentially through diet and exercise) may help prevent or manage insulin resistance.

Consumer confidence in food safety, healthfulness, sustainability, and authenticity is primarily determined by beliefs about the openness, competence, and care of food chain actors (manufacturers, farmers, retailers, authorities), with openness being the strongest predictor of confidence.

For food producers and policymakers, building consumer confidence requires prioritizing transparency (openness) and demonstrating competence. Since consumers cannot verify health or sustainability claims themselves, they rely on trust in the actors. Therefore, clear, honest communication and proven capability are more critical than the claims themselves.

Nonalcoholic fatty liver disease (NAFLD) is a systemic condition with multifactorial pathogenesis, not merely a hepatic manifestation of metabolic syndrome, and it can precede the development of metabolic syndrome and type 2 diabetes.

NAFLD is not just a liver issue; it is a systemic metabolic disorder that can drive diabetes and heart disease risk. Even if you are lean, genetic factors or gut health issues can cause it. Focus on metabolic health markers (blood sugar, lipids) rather than just weight, and prioritize lifestyle changes that improve insulin sensitivity and gut health, as these address the root multifactorial causes.

Genetic variants, specifically PNPLA3 I148M and TM6SF2 E167K, significantly increase the risk of liver disease progression and hepatocellular carcinoma in NAFLD patients, independent of metabolic syndrome severity.

If you have a family history of liver disease or known genetic variants like PNPLA3, you are at higher risk for liver damage even if your weight is normal. This means you need stricter monitoring of liver enzymes and fibrosis markers, and you must be aggressive with lifestyle interventions to reduce liver fat and inflammation.

Wearable sleep-tracking technology introduces healthcare disparities because sensor performance is negatively impacted by person-specific factors such as skin color and obesity, leading to inaccurate data for minority and obese populations.

If you have darker skin or obesity, be aware that consumer sleep wearables may be less accurate for you. Do not use these devices for critical health decisions without verifying their accuracy against clinical standards for your specific body type.

PPARα activation suppresses the liver secretome (including complement and coagulation factors) to conserve energy during fasting, whereas FXR activation induces secretion to support nutrient processing in the fed state.

Your liver actively manages energy by adjusting how much protein it secretes based on whether you are eating or fasting. In the fed state, it produces more proteins (like clotting factors and complement) to support nutrient processing. In the fasted state, it reduces this production to save energy. This suggests that nutritional strategies, particularly for those with metabolic issues or undernutrition, should consider the timing of nutrient intake to align with these natural hormonal switches (PPARα for fasting, FXR for feeding).

PPARα and FXR have opposing effects on autophagy: PPARα induces autophagy during fasting to recover nutrients, while FXR suppresses it during the fed state.

Your body uses autophagy (cellular recycling) to recover nutrients when you are fasting, driven by PPARα. When you eat, FXR suppresses this process. This natural cycle suggests that intermittent fasting may leverage this mechanism to clear cellular debris and recover nutrients, provided the fasting periods are sufficient to trigger PPARα activation.

High-dose phenolic compound supplementation can exhibit pro-oxidant effects and cause toxicity, including liver damage and accelerated tumorigenesis, in certain contexts.

Avoid high-dose polyphenol supplements. While dietary sources are safe, concentrated supplements can become pro-oxidant and cause liver stress or other toxic effects.

Downregulation of genes encoding mitochondrial proteins is a highly conserved hallmark of cellular ageing across multicellular eukaryotes, correlating with reduced mitochondrial function and lifespan.

Aging is associated with a consistent drop in the genetic instructions for making mitochondrial proteins. While this is a hallmark of aging, interventions like caloric restriction or metformin can reverse this specific gene expression change, suggesting that maintaining mitochondrial gene expression levels may be beneficial for healthspan.

Downregulation of ribosomal proteins and ribosome biogenesis factors is a conserved hallmark of cellular ageing, likely serving as a protective programme rather than a cause of pathology.

Aging involves a reduction in the genetic instructions for building ribosomes. This is not a defect but a protective mechanism. Interventions that extend lifespan, such as caloric restriction and rapamycin, also reduce these levels, suggesting that this downregulation is beneficial for longevity.

Dysregulation of immune system genes, specifically the upregulation of inflammation-associated genes (inflammaging), is a conserved transcriptional hallmark of cellular ageing.

Aging is associated with a consistent upregulation of immune and inflammation-related genes. This 'inflammaging' is linked to senescent cells and immune dysfunction. Interventions like metformin can reduce this inflammation, suggesting that managing chronic low-grade inflammation is relevant to healthspan.

Low leptin levels during weight loss increase brain activity in regions involved in emotional, cognitive, and sensory control of food intake, driving the desire to eat.

When you lose weight, your brain changes how it processes food images, making them more appealing and triggering decision-making areas associated with craving. This is a biological response to low leptin, not just a failure of willpower.

Acute high-intensity cycling exercise (70% VO2max for 60 minutes) causes a transient decrease in serum levels of the myokine PEDF, which normalizes within 120 minutes post-exercise, despite increased local secretion from contracting muscle cells.

If you perform 60 minutes of cycling at 70% of your maximum aerobic capacity, expect your blood levels of the protein PEDF to drop temporarily (up to 2 hours post-workout). This does not mean the exercise is ineffective; rather, it reflects complex distribution dynamics where the protein may be moving into tissues. Do not use a single post-workout blood test of PEDF to judge the efficacy of your training session.

Electrical pulse stimulation (EPS) of primary human myotubes increases the secretion of the myokine PEDF in vitro, even though mRNA expression levels remain unchanged, indicating post-transcriptional regulation.

This finding explains how muscles can rapidly release signaling proteins during exercise without immediately changing their genetic instructions. It highlights the efficiency of the muscular system in adapting to physical stress through pre-stored or rapidly released factors.

Females are protected from inflammation-induced muscle wasting (cancer cachexia) compared to males, likely due to estrogen's ability to blunt inflammatory responses and lower basal ubiquitin-proteasome activity.

For women undergoing cancer treatment involving cachexia, hormonal status (specifically estrogen) may offer some natural protection against severe muscle wasting compared to men. This doesn't mean muscle loss won't happen, but the mechanism is different. Maintaining hormonal balance and managing inflammation are key, as estrogen helps blunt the inflammatory signals that drive this specific type of muscle loss.

Elevated plasma Branched-Chain Amino Acids (BCAAs) are associated with insulin resistance and type 2 diabetes risk, though genetic evidence suggests insulin resistance may drive BCAA levels rather than the reverse.

High levels of BCAAs in your blood are a strong indicator of insulin resistance and future diabetes risk. Interestingly, genetic studies suggest that your body's inability to clear BCAAs (due to insulin resistance) causes the high levels, rather than the BCAAs causing the resistance. If you are insulin resistant, focus on improving metabolic health through diet and exercise rather than just supplementing BCAAs.

Chronic activation of AMP-activated protein kinase (AMPK) via AICAR remodels white adipose tissue metabolism to promote energy dissipation by upregulating fatty acid oxidation genes (PGC-1α, PPARα, PPARδ) and increasing Adipose Triglyceride Lipase (ATGL) content, while simultaneously suppressing Hormone-Sensitive Lipase (HSL) activity.

This research suggests that chronically stimulating the cellular energy sensor AMPK (using the drug AICAR in this study) can reprogram fat cells to burn more fat and store less, primarily by increasing the amount of a specific fat-burning enzyme (ATGL). However, this effect is not immediate and involves a complex interplay where another fat-burning enzyme (HSL) is actually suppressed. This highlights that simply 'activating' energy sensors is not a simple on/off switch for fat loss and may have delayed or counter-intuitive initial effects.

Calorie restriction extends lifespan and improves metabolic health in mammals by upregulating SIRT1 and SIRT3, which deacetylate and activate metabolic enzymes and transcription factors to shift cells from glycolysis to oxidative phosphorylation.

Calorie restriction (reducing intake to 60-70% of ad libitum levels) activates sirtuins (SIRT1 and SIRT3), which shift metabolism from glycolysis to oxidative phosphorylation, improving insulin sensitivity and extending lifespan in mice. While direct application to humans requires more research, the mechanism suggests that metabolic flexibility and mitochondrial health are key to longevity.

DL001 reduces the immunosuppressive effects of mTOR inhibition compared to rapamycin, specifically preserving more T cell and Treg populations.

This study shows that DL001, a selective mTORC1 inhibitor, causes less suppression of T cells and T regulatory cells than standard rapamycin in mice. This suggests that future human applications of selective mTOR inhibitors might have a better safety profile regarding immune function and infection risk, though human trials are needed to confirm this.

Bone marrow adipose tissue (BMAT) is functionally distinct from white and brown adipose tissues, exhibiting high basal glucose uptake but resisting insulin- and cold-stimulated glucose uptake.

Bone marrow fat is not just inert storage; it is a metabolically active tissue that consumes significant glucose at rest but does not respond to insulin or cold like other fats. This suggests that managing overall metabolic health involves factors beyond just visible subcutaneous or visceral fat, and that bone marrow fat may play a larger role in systemic glucose regulation than previously assumed.

SGLT-2 inhibitors produce modest weight loss (2.1-2.7 kg) in people with Type 2 Diabetes by inducing glucose-mediated osmotic diuresis, but are not yet approved specifically for obesity treatment.

SGLT-2 inhibitors (like Jardiance or Forxiga) are used for Type 2 Diabetes and cause modest weight loss (2-3 kg) by peeing out glucose. They are not approved for obesity treatment in non-diabetics, and the weight loss is less significant than with GLP-1 drugs.

Poor dietary intake in low-income groups is an emergent property of a complex adaptive system that sustains a food environment increasing the accessibility, availability, affordability, and acceptability of unhealthy foods.

For policymakers and advocates: Do not rely solely on 'food desert' fixes like new supermarkets. Interventions must simultaneously address household financial strain, social/cultural norms, and the systemic drivers that make unhealthy food the rational choice for low-income households.

Dietary intake in low-income groups is driven more by demand-side factors (social, cultural, economic) than by supply-side factors (accessibility, availability).

For health educators: Nutrition education alone is ineffective if it doesn't address the economic and social realities of low-income households. Interventions must focus on making healthy choices financially viable and socially supported, not just 'known'.

Resistance exercise-induced skeletal muscle hypertrophy is not solely dependent on rapamycin-sensitive mTOR signaling, as inhibiting this pathway only partially blocks muscle growth and protein synthesis.

You don't need to obsess over optimizing every single molecular signal to build muscle. While mTOR is important, your body has backup systems that allow muscle growth even if this specific pathway is dampened. Focus on consistent resistance training rather than trying to perfectly manipulate one specific biological mechanism.